DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6m9mjg/global_continuous) has announced the addition of the "Global Continuous Glucose Monitoring System (CGM Market, Integrated Insulin Pumps, MARD, SMBG, Growing Diabetic Population, Type 1&2 Diabetes, Nocturnal Hypoglycemia) Price, Industry Analysis, Market Growth, Market Share, Forecasts 2014 - 2020" report to their offering.
Continuous glucose monitoring System (CGMS) are medical devices which enable the diabetic patients to track their glucose levels. Sensor, transmitter and receiver are the main components of CGMS devices which are available in the price range of $1000 to $1500. CGMS market is gradually increasing due to increase in diabetes patients and pouring investment in research and development. Globally, the major market for CGMS devices is North America which is responsible for 80% of the contribution in total revenues. The CGMS market has been facing tough competition from Self monitoring of blood glucose (SMBG) device market.
North America will continue to be the huge market for CGMS and SMBG devices. However, 80 % of the total diabetic patients are from emerging economies such as India and China. These are untapped market and the healthcare companies must explore this market for increasing revenues and profit.
- Echo Therapeutics
- Insulet Corp
- Johnson and Johnson (J&J) (Animas Corp)
- Medtronic Inc.
- Tandem Diabetes
For more information visit http://www.researchandmarkets.com/research/6m9mjg/global_continuous
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.